All Publications for Antitrust and Competition Policy in the Health Care Industry


An Inside Look at Monopsony Issues in the FTC's Express Scripts-Medco Merger InvestigationPublished Article
2012-09-15
By John Scalf with Rani Habash of Dechert LLP
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development ExpendituresWorking Paper
2010-02-01
By Dr. Graeme Hunter with Dr. John Vernon and Dr. Joseph Cook
Schering-Plough and the Antitrust Analysis of Patent Settlement Agreements in Pharmaceutical MarketsBook Chapter
2007-05-30
By Dr. Sumanth Addanki

Antitrust and Patent Settlement InvestigationsPublished Article
2007-05-01
By David Monk with former NERA Vice President Dr. Joseph Cook
Competition and Innovation in Health Care Markets and Their Implications for Antitrust EnforcementPublished Article
2005-03-01
By Dr. Lawrence Wu with former NERA Senior Consultant Dr. Rika Mortimer
Antitrust Treatment of Mergers Involving Future GoodsPublished Article
2004-12-31
By Richard T. Rapp with Ilene Knable Gotts, Partner at Wachtell, Lipton Rosen & Katz
Geographic Market Issues in Hospital MergersPublished Article
2003-06-30
By Dr. Thomas McCarthy and Dr. Scott Thomas
Are Mergers the Right Medicine for Japan's Pharmaceutical Industry?Presentation
2002-10-20
By Dr. Richard Rapp
Antitrust Issues Between Payers and ProvidersPublished Article
2002-03-01
By Dr. Thomas McCarthy and Dr. Scott Thomas
Efficiencies Analysis in Hospital MergersPublished Article
1999-12-01
By Dr. Thomas McCarthy, Dr. Scott Thomas and Dr. Lawrence Wu